Hormonal regulation of gonadotropin-releasing hormone receptors and messenger RNA activity in ovine pituitary culture.
Previous studies demonstrate that gonadotroph responsiveness to GnRH, GnRH binding, and the apparent number of GnRH receptors are all increased by 17 beta-estradiol (E) or inhibin (IN) in ovine pituitary cultures. Progesterone (P) attenuates these effects. To explore differences between the effects of IN and E on GnRH binding, a detailed time-course study was performed. The results indicate that after 48 h, IN had a greater effect on binding of a GnRH agonist (5-fold increase) than E (3-fold increase), but was slower to act initially. A combined treatment of IN and E gave a partially additive effect at 48 h (6.5-fold increase). The mechanism of receptor regulation in this system is not known, but could involve synthesis, recycling, or modification of GnRH receptors. To investigate the contribution of altered receptor biosynthesis to the regulation of receptor levels, a functional Xenopus oocyte-based assay for GnRH receptor mRNA activity was employed. After 48 h of treatment, IN or E each led to a 7- to 8-fold increase in GnRH receptor mRNA activity. Treatment with both hormones led to a 19-fold increase. The increase in mRNA activity induced by either hormone was greatly attenuated by P. Modulation of GnRH receptor mRNA levels suggests that IN, E, and P regulate responsiveness to GnRH in the ovine pituitary at least in part by altering de novo synthesis of GnRH receptors. The differing time courses of action, as assayed by GnRH binding, and the additivity of effects at the mRNA level suggest that IN and E alter mRNA levels via different mechanisms.
Sealfon
S C
SC
Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029.
Laws
S C
SC
Wu
J C
JC
Gillo
B
B
Miller
W L
WL
D000818:Animals; D002478:Cells, Cultured; D004594:Electrophysiology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D015870:Gene Expression; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000378:metabolism; D007265:Inhibins / Q000494:pharmacology*; D007700:Kinetics; D009865:Oocytes / Q000502:physiology; D011374:Progesterone / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism*; D011966:Receptors, LHRH / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D012756:Sheep; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014162:Transfection; D014982:Xenopus laevis
D012333:RNA, Messenger; D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D004958:Estradiol; D007265:Inhibins; D013973:Thyrotropin-Releasing Hormone